Dr Reddy’s Laboratories has launched Metoprolol Succinate ER (Extended-Release) tablets (25 mg, 50 mg, 100 mg and 200 mg), a bioequivalent generic version of Toprol-XL (Metoprolol Succinate) tablets in the US market. The tablets have been approved by the United States Food & Drug Administration (US FDA) in August 2012.
The Toprol-XL brand and generic had US sales of approximately $1.13 billion for the most recent twelve months ending June 2012 according to IMS Health.
Dr Reddy’s Metoprolol Succinate ER tablets in 25 mg, 50 mg, 100 mg and 200 mg are available in bottle counts of 100 and 500.
EP News Bureau
- Advertisement -
